SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-139366
Filing Date
2024-05-15
Accepted
2024-05-15 16:06:47
Documents
15
Period of Report
2024-05-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d787110d8k.htm   iXBRL 8-K 27647
2 EX-99.1 d787110dex991.htm EX-99.1 71377
  Complete submission text file 0001193125-24-139366.txt   280627

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mreo-20240515.xsd EX-101.SCH 3556
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mreo-20240515_def.xml EX-101.DEF 14947
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mreo-20240515_lab.xml EX-101.LAB 24641
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mreo-20240515_pre.xml EX-101.PRE 15915
18 EXTRACTED XBRL INSTANCE DOCUMENT d787110d8k_htm.xml XML 6138
Mailing Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF
Business Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF 4403330237300
Mereo BioPharma Group plc (Filer) CIK: 0001719714 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38452 | Film No.: 24950494
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)